Since ε2 carriers have lower levels of serum total cholesterol than non-ε2 carriers, our findings suggest that the increased risk effect for gastric cancer by APOE ε2 allele might be mediated through lowered total cholesterol level. The gene discussed is APOE; the disease is gastric cancer.